This is particular important in order to increase the ability to predict PCa development; although only 13 patients developed a new cancer during follow up, the ROC analyses showed that DKK-1 performed slightly better than PSA in detecting these patients. The gene discussed is KLK3; the disease is posterior cortical atrophy.